HUTCHMED (China) (HCM) Receivables - Net (2015 - 2026)
HUTCHMED (China) (HCM) posted quarterly Receivables - Net of $117.6 million for Q2 2026, down 20.01% year-over-year from $147.0 million in Q2 2025, and up 621.33% quarter-over-quarter from $16.3 million in Q4 2025.
HUTCHMED (China) (HCM) Receivables - Net (2015 - 2026) Analysis & Trends
HUTCHMED (China) (HCM) has reported Receivables - Net for 12 consecutive years, with $117.6 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Receivables - Net fell 20.01% year-over-year to $117.6 million; the TTM figure through Jun 2026 stood at $117.6 million (down 20.01% YoY), while the FY2025 annual figure was $16.3 million, down 18.24% from the prior year.
- Receivables - Net climbed to $117.6 million in Q2 2026 per HCM's latest filing, from $16.3 million in the prior quarter.
- Across five years, Receivables - Net topped out at $15.0 billion in Q4 2023 and bottomed at $12.5 million in Q4 2022.
- Historically, Receivables - Net has averaged $1.7 billion across 5 years, with a median of $117.6 million in 2026.
- Annual changes were most pronounced in 2023 — Receivables - Net jumped 119327.04% — and 2024, when it plunged 99.87%.
- HUTCHMED (China)'s Receivables - Net stood at $12.5 million in 2022, then surged by 119327.04% to $15.0 billion in 2023, then slumped by 99.87% to $20.0 million in 2024, then slipped by 18.54% to $16.3 million in 2025, then jumped by 621.33% to $117.6 million in 2026.
- Business Quant data shows HCM's Receivables - Net at $117.6 million in Q2 2026, $16.3 million in Q4 2025, and $147.0 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | HUTCHMED (China) | 2.18 Bn | 2.18 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 117.56 Mn |
| Jun 30, 2026 | 117.56 Mn |
| Dec 31, 2025 | 16.30 Mn |
| Dec 31, 2025 | 16.30 Mn |
| Jun 30, 2025 | 146.97 Mn |
| Jun 30, 2025 | 146.97 Mn |
| Dec 31, 2024 | 20.01 Mn |
| Dec 31, 2024 | 20.01 Mn |
| Jun 30, 2024 | 156.92 Mn |
| Jun 30, 2024 | 156.92 Mn |
| Dec 31, 2023 | 14.96 Bn |
| Dec 31, 2023 | 14.96 Bn |
| Jun 30, 2023 | 129.20 Mn |
| Jun 30, 2023 | 129.20 Mn |
| Dec 31, 2022 | 12.53 Mn |
| Dec 31, 2022 | 12.53 Mn |
| Jun 30, 2022 | 77.08 Mn |
| Jun 30, 2022 | 77.08 Mn |
| Dec 31, 2021 | 10.73 Mn |
| Dec 31, 2021 | 10.73 Mn |